Recently, Route Scouting (RS) for preclinical and clinical development has emerged as an important area of interest. Identifying the most efficient route. reduces not only the timeline for critical milestones, but also improves cost and atom efficiency. In this webinar, we will present an overview on RS, recommendations on when to engage in a RS program, our approach on RS, and finally, examples of challenges that have been addressed in preclinical/ clinical development, through commercial/ life-cycle management of APIs.
Dr. Murali Rajappa
General Manager, R&D